Autonomic Dysfunction: A Driving Force for Myocardial Fibrosis in Young Duchenne Muscular Dystrophy Patients?

被引:37
|
作者
Thomas, Tamara O. [1 ]
Jefferies, John L. [1 ]
Lorts, Angela [1 ]
Anderson, Jeffrey B. [1 ]
Gao, Zhiqian [1 ]
Benson, D. Woodrow [2 ]
Hor, Kan N. [3 ]
Cripe, Linda H. [3 ]
Urbina, Elaine M. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[2] Childrens Hosp Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[3] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA
关键词
Duchenne; Cardiomyopathy; Myocardial fibrosis; Heart rate variability; Tachycardia; HEART-RATE-VARIABILITY; FREQUENCY-DOMAIN MEASURES; CIRCUMFERENTIAL STRAIN; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; PERIOD VARIABILITY; INFARCTION; FAILURE; TIME;
D O I
10.1007/s00246-014-1050-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac manifestations of Duchenne muscular dystrophy (DMD) include progressive cardiac dysfunction and an elevated resting heart rate (HR). We hypothesized this elevated HR reflects autonomic dysfunction that can be identified by heart rate variability (HRV) analyses which will be associated with myocardial fibrosis by cardiac magnetic resonance imaging (cMR). DMD patients (N = 74) and controls (N = 17) had time and frequency domain HRV analyses calculated via Holter monitoring. Cardiac magnetic resonance imaging was performed on DMD cases only. chi (2) test, T test, ANOVA, and logistic regression were used to perform comparisons between groups. A p value of < 0.05 was used for statistical significance. DMD cases had higher resting average HR than controls (99.4 +/- A 8.9, 85.4 + 6.2, p < 0.001). Among HRV variables, decreases were seen in the following: standard deviation of R to R intervals, the percent RR intervals differing by > 50 ms from previous RR interval, the root-meansquare of successive differences of RR intervals, the standard deviation of the mean R to R segment (SDANN), low frequency, and high frequency domain, all p values 0.001. Maximum HR and SDANN most significantly associated with positive LGE on cMR (p = 0.008, p = 0.016). DMD cases on beta blocker had an average HR lower than those not on beta blocker (p = 0.009), but with no difference in HRV analysis. DMD patients have reduced HRV and therefore autonomic dysfunction prior to the onset of heart failure which is associated with myocardial fibrosis.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 50 条
  • [21] Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review
    Talita Dias da Silva
    Thais Massetti
    Tânia Brusque Crocetta
    Carlos Bandeira de Mello Monteiro
    Alex Carll
    Luiz Carlos Marques Vanderlei
    Carlie Arbaugh
    Fernando Rocha Oliveira
    Luiz Carlos de Abreu
    Celso Ferreira Filho
    John Godleski
    Celso Ferreira
    Pediatric Cardiology, 2018, 39 : 869 - 883
  • [22] Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review
    da Silva, Talita Dias
    Massetti, Thais
    Crocetta, Tania Brusque
    de Mello Monteiro, Carlos Bandeira
    Carll, Alex
    Marques Vanderlei, Luiz Carlos
    Arbaugh, Carlie
    Oliveira, Fernando Rocha
    de Abreu, Luiz Carlos
    Filho, Celso Ferreira
    Godleski, John
    Ferreira, Celso
    PEDIATRIC CARDIOLOGY, 2018, 39 (05) : 869 - 883
  • [23] Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging
    Sean M. Lang
    Svetlana Shugh
    Wojciech Mazur
    Joshua J. Sticka
    Mantosh S. Rattan
    John L. Jefferies
    Michael D. Taylor
    Pediatric Cardiology, 2015, 36 : 1495 - 1501
  • [24] Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy A Randomized Clinical Trial
    Silva, Marly Conceicao
    Magalhaes, Tiago Augusto
    Alves Meira, Zilda Maria
    Reis Esselin Rassi, Carlos Henrique
    de Souza Andrade, Amanda Cristina
    Gutierrez, Paulo Sampaio
    Azevedo, Clerio Francisco
    Gurgel-Giannetti, Juliana
    Vainzof, Mariz
    Zatz, Mayana
    Kalil-Filho, Roberto
    Rochitte, Carlos Eduardo
    JAMA CARDIOLOGY, 2017, 2 (02) : 190 - 199
  • [25] PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
    Farini, Andrea
    Villa, Chiara
    Di Silvestre, Dario
    Bella, Pamela
    Tripodi, Luana
    Rossi, Rossana
    Sitzia, Clementina
    Gatti, Stefano
    Mauri, Pierluigi
    Torrente, Yvan
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [26] Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice
    Vincenti, Marie
    Farah, Charlotte
    Amedro, Pascal
    Scheuermann, Valerie
    Lacampagne, Alain
    Cazorla, Olivier
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 793 - 803
  • [27] Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice
    Marie Vincenti
    Charlotte Farah
    Pascal Amedro
    Valerie Scheuermann
    Alain Lacampagne
    Olivier Cazorla
    Cardiovascular Drugs and Therapy, 2022, 36 : 793 - 803
  • [28] Left ventricular strain-volume loops and myocardial fibrosis in pediatric patients with Duchenne muscular dystrophy
    Kerstens, Thijs P.
    van Everdingen, Wouter M.
    ten Cate, Floris E. A. Udink
    Thijssen, Dick H. J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 395
  • [29] Left ventricular dysfunction in Duchenne muscular dystrophy
    James, Katherine A.
    Gralla, Jane
    Ridall, Leslie A.
    Do, ThuyQuynh N.
    Czaja, Angela S.
    Mourani, Peter M.
    Ciafaloni, Emma
    Cunniff, Christopher
    Donnelly, Jennifer
    Oleszek, Joyce
    Pandya, Shree
    Price, Elinora
    Yang, Michele L.
    Auerbach, Scott R.
    CARDIOLOGY IN THE YOUNG, 2020, 30 (02) : 171 - 176
  • [30] Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study
    Aikawa, Tadao
    Takeda, Atsuhito
    Oyama-Manabe, Noriko
    Naya, Masanao
    Yamazawa, Hirokuni
    Koyanagawa, Kazuhiro
    Ito, Yoichi M.
    Anzai, Toshihisa
    PEDIATRIC CARDIOLOGY, 2019, 40 (02) : 384 - 392